HAIN:NASDAQThe Hain Celestial Group, Inc. Analysis
Data as of 2026-05-19 - not real-time
$0.74
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The stock is trading at $0.74, well below its 20‑day (≈$0.77) and 50‑day (≈$0.75) simple moving averages and far under the 200‑day SMA (≈$1.17), indicating a technical oversold condition. Momentum indicators are mixed: RSI sits near 48 (neutral), while the MACD histogram turned positive and the MACD line crossed above its signal, signaling a tentative bullish shift. Volume has been decreasing and the 30‑day volatility exceeds 120%, reflecting a highly erratic price environment. On the fundamentals side, revenue is contracting (‑13% YoY) and the company posted a sizable loss margin (‑35%), with a debt‑to‑equity ratio above 260%, yet free cash flow remains positive and the DCF model suggests a fair value of roughly $11.6, implying >80% upside. Recent news of a “strategic overhaul” and upcoming Q3 earnings release have sparked a modest share surge, and the market sentiment index reads “Extreme Greed.”
Overall, the stock presents a classic value paradox: deep discount to intrinsic estimates but encumbered by weak profitability, high leverage, and pronounced price volatility. Investors must weigh the potential upside from a turnaround against the substantial execution and financial risks.
Overall, the stock presents a classic value paradox: deep discount to intrinsic estimates but encumbered by weak profitability, high leverage, and pronounced price volatility. Investors must weigh the potential upside from a turnaround against the substantial execution and financial risks.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering near recent support at $0.55
- Bullish MACD crossover suggests limited near‑term upside
- High volatility and decreasing volume increase short‑term uncertainty
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF‑derived upside of >80% versus current price
- Strategic overhaul may improve margin trajectory
- Forward EPS turning positive indicates potential earnings recovery
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Deep discount to book (P/B ≈0.2) offers value cushion
- Consumer‑defensive positioning in organic/natural foods supports secular growth
- Resolution of debt load and sustained cash flow generation are critical catalysts
Key Metrics & Analysis
Financial Health
Revenue Growth-13.30%
Profit Margin-35.47%
P/E Ratio7.0
ROE-113.04%
ROA1.39%
Debt/Equity276.41
P/B Ratio0.2
Op. Cash Flow$64.2M
Free Cash Flow$122.9M
Technical Analysis
TrendNeutral
RSI47.7
Support$0.55
Resistance$0.97
MA 20$0.77
MA 50$0.75
MA 200$1.17
MACDBullish
VolumeDecreasing
Fear & Greed Index89.61
Valuation
Fair Value$11.58
Target Price$1.34
Upside/Downside80.44%
GradeUndervalued
TypeValue
Risk Assessment
Beta2.12
Volatility123.34%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.